An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the coronavirus disease-19 (COVID-19) pandemic, was identified in late 2019 and caused >5 million deaths by February 2022. To date, targeted antiviral interventions against COVID-19 are limited. The spectrum of SARS-CoV-2...
Main Authors: | Lindsay Broadbent, Connor G G Bamford, Guillermo Lopez Campos, Sheerien Manzoor, David Courtney, Ahlam Ali, Olivier Touzelet, Conall McCaughey, Ken Mills, Ultan F Power |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0266412 |
Similar Items
-
Comparison of SARS-CoV-2 Evolution in Paediatric Primary Airway Epithelial Cell Cultures Compared with Vero-Derived Cell Lines
by: Connor G. G. Bamford, et al.
Published: (2022-02-01) -
Airway Epithelial Derived Cytokines and Chemokines and Their Role in the Immune Response to Respiratory Syncytial Virus Infection
by: Lena Glaser, et al.
Published: (2019-07-01) -
Antiviral Activity of an Endogenous Parvoviral Element
by: Angelica Bravo, et al.
Published: (2023-06-01) -
Directly reprogrammed fragile X syndrome dorsal forebrain precursor cells generate cortical neurons exhibiting impaired neuronal maturation
by: Nicole Edwards, et al.
Published: (2023-09-01) -
Evolution: endogenous viruses provide shortcuts in antiviral immunity
by: Katzourakis, A, et al.
Published: (2016)